Jaguar Health, Inc. (NASDAQ:JAGX) Sees Large Increase in Short Interest

Jaguar Health, Inc. (NASDAQ:JAGX) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 51,100 shares, a growth of 43.1% from the March 15th total of 35,700 shares. Based on an average daily volume of 24,800 shares, the days-to-cover ratio is currently 2.1 days. Approximately 9.2% of the shares of the company are short sold.

Hedge Funds Weigh In On Jaguar Health

A hedge fund recently bought a new stake in Jaguar Health stock. Virtu Financial LLC acquired a new stake in shares of Jaguar Health, Inc. (NASDAQ:JAGX) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health as of its most recent filing with the Securities and Exchange Commission (SEC). 12.04% of the stock is currently owned by hedge funds and other institutional investors.

Jaguar Health Trading Down 1.8 %

Shares of JAGX opened at $5.51 on Friday. Jaguar Health has a 52-week low of $4.02 and a 52-week high of $540.00. The stock’s 50-day simple moving average is $10.90 and its 200 day simple moving average is $20.45. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.84 and a quick ratio of 1.36.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Jaguar Health in a research note on Friday, March 28th. They set a “sell” rating on the stock.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.